Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer

PURPOSE: Pancreatic cancer (PC) has poor prognosis despite systemic treatment. Dehydrogenase/reductase member 9 (DHRS9) has been reported to be involved in many events of tumorigenesis, but its prognostic impact in PC remains undetermined. Thus, this study aimed to explore the association between DH...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Huang-bao, Zhou, Jun, Zhao, Fengqing, Yu, Jiayin, Xu, Longsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381829/
https://www.ncbi.nlm.nih.gov/pubmed/32765099
http://dx.doi.org/10.2147/CMAR.S251897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381829/
https://www.ncbi.nlm.nih.gov/pubmed/32765099
http://dx.doi.org/10.2147/CMAR.S251897

Ejemplares similares